Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081396039> ?p ?o ?g. }
- W3081396039 endingPage "494" @default.
- W3081396039 startingPage "486" @default.
- W3081396039 abstract "Objectives: The present study characterized the psychiatric diagnoses and symptoms that led to the administration of antipsychotic medications in children and adolescents with cancer, and to evaluate the benefits and tolerability of these drugs in a large hospital-based pediatric hematology–oncology practice. Methods: Efficacy and adverse effects of two second-generation antipsychotics were retrospectively analyzed in 43 patients 2.9–19.6 (mean 12.1) years of age. The Clinical Global Impression-Severity (CGI-S) Scale and Improvement (CGI-I) Scale were used to evaluate psychiatric symptom severity before and following treatment, while the incidence of side effects and drug–drug interactions were collected from medical records. Results: Olanzapine was administered to 58% of patients and risperidone to 42%; the choice of drug was at the discretion of the treating psychiatrist. The common psychiatric diagnoses among these patients included adjustment disorder (37%) and medication-induced psychiatric disorders (23%). The most common psychiatric-medical symptoms included irritability/agitation (79%) and depressed mood (74%). CGI-S improved significantly (p < 0.001) between assessments, with no statistically significant difference between olanzapine- and risperidone-treated patients. CGI-I scores at reassessment indicated superiority of olanzapine as compared with risperidone. Adverse effects of treatment were mild. Conclusions: Olanzapine and risperidone can be well tolerated and ameliorate severe psychiatric-medical symptoms in children and adolescents with cancer. The potential palliative benefits of these second-generation antipsychotics (e.g., rapid onset of action, antiemesis, sedation, and appetite stimulation) increase the utility of their use in children treated in oncology and bone marrow transplant units." @default.
- W3081396039 created "2020-09-01" @default.
- W3081396039 creator A5003379128 @default.
- W3081396039 creator A5003750564 @default.
- W3081396039 creator A5012792687 @default.
- W3081396039 creator A5018866586 @default.
- W3081396039 creator A5036767793 @default.
- W3081396039 creator A5043164298 @default.
- W3081396039 creator A5057004066 @default.
- W3081396039 creator A5059542536 @default.
- W3081396039 creator A5062476472 @default.
- W3081396039 creator A5063898483 @default.
- W3081396039 creator A5085154659 @default.
- W3081396039 creator A5087340987 @default.
- W3081396039 creator A5088747140 @default.
- W3081396039 date "2020-10-01" @default.
- W3081396039 modified "2023-10-14" @default.
- W3081396039 title "Psychopharmacology in the Pediatric Oncology and Bone Marrow Transplant Units: Antipsychotic Medications Palliate Symptoms in Children with Cancer" @default.
- W3081396039 cites W1800910670 @default.
- W3081396039 cites W1949415364 @default.
- W3081396039 cites W1965738210 @default.
- W3081396039 cites W1966630251 @default.
- W3081396039 cites W1968275141 @default.
- W3081396039 cites W1970519890 @default.
- W3081396039 cites W1974615135 @default.
- W3081396039 cites W1979996897 @default.
- W3081396039 cites W1982855918 @default.
- W3081396039 cites W1985307995 @default.
- W3081396039 cites W1985517071 @default.
- W3081396039 cites W1985921793 @default.
- W3081396039 cites W1989268671 @default.
- W3081396039 cites W1990508212 @default.
- W3081396039 cites W1992203573 @default.
- W3081396039 cites W2012693180 @default.
- W3081396039 cites W2033586528 @default.
- W3081396039 cites W2046142845 @default.
- W3081396039 cites W2050391762 @default.
- W3081396039 cites W2059304111 @default.
- W3081396039 cites W2059411701 @default.
- W3081396039 cites W2073000449 @default.
- W3081396039 cites W2097010889 @default.
- W3081396039 cites W2109861972 @default.
- W3081396039 cites W2110924135 @default.
- W3081396039 cites W2120051206 @default.
- W3081396039 cites W2121783482 @default.
- W3081396039 cites W2140709108 @default.
- W3081396039 cites W2150533419 @default.
- W3081396039 cites W2151161350 @default.
- W3081396039 cites W2155871346 @default.
- W3081396039 cites W2172241494 @default.
- W3081396039 cites W2293785325 @default.
- W3081396039 cites W2519662568 @default.
- W3081396039 cites W2532663360 @default.
- W3081396039 cites W2571458784 @default.
- W3081396039 cites W2579472977 @default.
- W3081396039 cites W2594900021 @default.
- W3081396039 cites W2753167281 @default.
- W3081396039 cites W2758178299 @default.
- W3081396039 cites W2809514332 @default.
- W3081396039 cites W2891849488 @default.
- W3081396039 cites W4243894673 @default.
- W3081396039 cites W4247665917 @default.
- W3081396039 cites W2619161413 @default.
- W3081396039 doi "https://doi.org/10.1089/cap.2019.0164" @default.
- W3081396039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32845729" @default.
- W3081396039 hasPublicationYear "2020" @default.
- W3081396039 type Work @default.
- W3081396039 sameAs 3081396039 @default.
- W3081396039 citedByCount "4" @default.
- W3081396039 countsByYear W30813960392021 @default.
- W3081396039 countsByYear W30813960392022 @default.
- W3081396039 countsByYear W30813960392023 @default.
- W3081396039 crossrefType "journal-article" @default.
- W3081396039 hasAuthorship W3081396039A5003379128 @default.
- W3081396039 hasAuthorship W3081396039A5003750564 @default.
- W3081396039 hasAuthorship W3081396039A5012792687 @default.
- W3081396039 hasAuthorship W3081396039A5018866586 @default.
- W3081396039 hasAuthorship W3081396039A5036767793 @default.
- W3081396039 hasAuthorship W3081396039A5043164298 @default.
- W3081396039 hasAuthorship W3081396039A5057004066 @default.
- W3081396039 hasAuthorship W3081396039A5059542536 @default.
- W3081396039 hasAuthorship W3081396039A5062476472 @default.
- W3081396039 hasAuthorship W3081396039A5063898483 @default.
- W3081396039 hasAuthorship W3081396039A5085154659 @default.
- W3081396039 hasAuthorship W3081396039A5087340987 @default.
- W3081396039 hasAuthorship W3081396039A5088747140 @default.
- W3081396039 hasConcept C118552586 @default.
- W3081396039 hasConcept C126322002 @default.
- W3081396039 hasConcept C142724271 @default.
- W3081396039 hasConcept C197934379 @default.
- W3081396039 hasConcept C204787440 @default.
- W3081396039 hasConcept C27081682 @default.
- W3081396039 hasConcept C2776000289 @default.
- W3081396039 hasConcept C2776412080 @default.
- W3081396039 hasConcept C2776619155 @default.
- W3081396039 hasConcept C2778375690 @default.
- W3081396039 hasConcept C2779727114 @default.
- W3081396039 hasConcept C2780057945 @default.